BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 16780024)

  • 1. Pap smear screening in women under 30 in the Norwegian Coordinated Cervical Cancer Screening Program, with a comparison of immediate biopsy vs Pap smear triage of moderate dysplasia.
    Nygård JF; Nygård M; Skare GB; Thoresen SO
    Acta Cytol; 2006; 50(3):295-302. PubMed ID: 16780024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CIN 2/3 and cervical cancer after an ASCUS pap smear. A 7-year, prospective study of the Norwegian population-based, coordinated screening program.
    Nygård JF; Sauer T; Skjeldestad FE; Skare GB; Thoresen SØ
    Acta Cytol; 2003; 47(6):991-1000. PubMed ID: 14674068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening histories of women with CIN 2/3 compared with women diagnosed with invasive cervical cancer: a retrospective analysis of the Norwegian Coordinated Cervical Cancer Screening Program.
    Nygård JF; Nygård M; Skare GB; Thoresen SØ
    Cancer Causes Control; 2005 May; 16(4):463-74. PubMed ID: 15953989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of cervical intraepithelial neoplasia grade III, and cancer of the cervix uteri following a negative Pap-smear in an opportunistic screening.
    Gram IT; Macaluso M; Stalsberg H
    Acta Obstet Gynecol Scand; 1998 Feb; 77(2):228-32. PubMed ID: 9512333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.
    Arbyn M; Buntinx F; Van Ranst M; Paraskevaidis E; Martin-Hirsch P; Dillner J
    J Natl Cancer Inst; 2004 Feb; 96(4):280-93. PubMed ID: 14970277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CIN 2/3 and cervical cancer in an organised screening programme after an unsatisfactory or a normal Pap smear: a seven-year prospective study of the Norwegian population-based screening programme.
    Nygård JF; Sauer T; Nygård M; Skare GB; Thoresen SØ
    J Med Screen; 2004; 11(2):70-6. PubMed ID: 15153321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Pap smear' for screening of precancerous conditions of cervix.
    Noreen R; Qudussi H
    J Ayub Med Coll Abbottabad; 2011; 23(2):41-4. PubMed ID: 24800339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Wait-and-see policy versus loop excision after two consecutive Pap-2 cervical smears: over time less surgery and an equivalent outcome; no substantial contribution to be expected from the detection of high risk human papillomavirus].
    Bekkers RL; Hanselaar AG; Melchers WJ; van Schaik JH; Boonstra H; Massuger LF
    Ned Tijdschr Geneeskd; 2003 Feb; 147(7):302-6. PubMed ID: 12622008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of pap smears and immunocytochemical detection of the p16 and Ki67 proteins in women with cervical intraepithelial neoplasia and cervical cancer].
    Rokita W; Skawiński D; Zmelonek-Znamirowska A; Kedzia W; Karowicz-Bilińska A; Spaczyński R; Spaczyński M
    Ginekol Pol; 2012 Nov; 83(11):822-6. PubMed ID: 23379189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: a cohort study with 10 years of follow-up.
    Sultana F; English DR; Simpson JA; Canfell K; Gertig DM; Saville M
    Int J Cancer; 2014 Sep; 135(5):1213-9. PubMed ID: 24488882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective evaluation of "see and treat" in women with HSIL Pap smear results: is this an appropriate strategy?
    Numnum TM; Kirby TO; Leath CA; Huh WK; Alvarez RD; Straughn JM
    J Low Genit Tract Dis; 2005 Jan; 9(1):2-6. PubMed ID: 15870514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?
    Subramaniam A; Fauci JM; Schneider KE; Whitworth JM; Erickson BK; Kim K; Huh WK
    J Low Genit Tract Dis; 2011 Apr; 15(2):110-3. PubMed ID: 21263352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of 10,296 pediatric and adolescent Papanicolaou smear diagnoses in northern New England.
    Mount SL; Papillo JL
    Pediatrics; 1999 Mar; 103(3):539-45. PubMed ID: 10049953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
    Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Borgatta L; Buck H; Kramer L; Rubin R
    J Fam Pract; 1998 Feb; 46(2):125-34. PubMed ID: 9487318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical neoplasia in pap smears: risk of cervical intra-epithelial neoplasia (CIN) after negative or no prior smears in a population without a mass screening programme.
    Forsmo S; Jacobsen BK; Stalsberg H
    Int J Epidemiol; 1996 Feb; 25(1):53-8. PubMed ID: 8666505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The borderline cervical smear: colposcopic and biopsy outcome.
    al-Nafussi A; Rebello G; al-Yusif R; McGoogan E
    J Clin Pathol; 2000 Jun; 53(6):439-44. PubMed ID: 10911801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with negative cervical biopsies after papanicolaou test interpretations of "atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion": comparative longitudinal follow-up.
    Huitron S; Bonvicino A; Fadare O
    Ann Diagn Pathol; 2008 Jun; 12(3):187-90. PubMed ID: 18486894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
    Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
    J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness.
    Kaufman RH; Adam E; Icenogle J; Reeves WC
    Am J Obstet Gynecol; 1997 Oct; 177(4):930-6. PubMed ID: 9369847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women's experience of coping with a positive Pap smear: A register-based study of women with two consecutive Pap smears reported as CIN 1.
    Ideström M; Milsom I; Andersson-Ellström A
    Acta Obstet Gynecol Scand; 2003 Aug; 82(8):756-61. PubMed ID: 12848648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.